|
1
|
Parrella A, Lavorgna M, Criscuolo E, Russo
C and Isidori M: Ecogenotoxicity of six anticancer drugs using
comet assay in daphnids. J Hazard Mater. 286:573–580. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li X, Tian J, Bo Q, Li K, Wang H, Liu T
and Li J: Targeting DNA-PKcs increased anticancer drug sensitivity
by suppressing DNA damage repair in osteosarcoma cell line MG63.
Tumour Biol. 36:9365–9372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu LP, Cao XC, Liu F, Quan MF, Sheng XF
and Ren KQ: Casticin induces breast cancer cell apoptosis by
inhibiting the expression of forkhead box protein M1. Oncol Lett.
7:1711–1717. 2014.PubMed/NCBI
|
|
4
|
Weisskopf M, Schaffner W, Jundt G, Sulser
T, Wyler S and Tullberg-Reinert H: A Vitex agnus-castus extract
inhibits cell growth and induces apoptosis in prostate epithelial
cell lines. Planta Med. 71:910–916. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haïdara K, Zamir L, Shi QW and Batist G:
The flavonoid casticin has multiple mechanisms of tumor
cytotoxicity action. Cancer Lett. 242:180–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Imai M, Kikuchi H, Denda T, Ohyama K,
Hirobe C and Toyoda H: Cytotoxic effects of flavonoids against a
human colon cancer derived cell line, COLO 201: A potential natural
anti-cancer substance. Cancer Lett. 276:74–80. 2009. View Article : Google Scholar
|
|
7
|
Tang SY, Zhong MZ, Yuan GJ, Hou SP, Yin
LL, Jiang H and Yu ZY: Casticin, a flavonoid, potentiates
TRAIL-induced apoptosis through modulation of anti-apoptotic
proteins and death receptor 5 in colon cancer cells. Oncol Rep.
29:474–480. 2013.
|
|
8
|
Koh DJ, Ahn HS, Chung HS, Lee H, Kim Y,
Lee JY, Kim DG, Hong M, Shin M and Bae H: Inhibitory effects of
casticin on migration of eosinophil and expression of chemokines
and adhesion molecules in A549 lung epithelial cells via NF-κB
inactivation. J Ethnopharmacol. 136:399–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Y, Peng Y, Mao QQ, Li X, Chen MW, Su
J, Tian L, Mao NQ, Long LZ, Quan MF, et al: Casticin induces
caspase-mediated apoptosis via activation of mitochondrial pathway
and upregu-lation of DR5 in human lung cancer cells. Asian Pac J
Trop Med. 6:372–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng F, Tian L, Liu F, Cao J, Quan M and
Sheng X: Induction of apoptosis by casticin in cervical cancer
cells: Reactive oxygen species-dependent sustained activation of
Jun N-terminal kinase. Acta Biochim Biophys Sin (Shanghai).
44:442–449. 2012. View Article : Google Scholar
|
|
11
|
Zhou Y, Tian L, Long L, Quan M, Liu F and
Cao J: Casticin potentiates TRAIL-induced apoptosis of gastric
cancer cells through endoplasmic reticulum stress. PLoS One.
8:e588552013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang L, Cao XC, Cao JG, Liu F, Quan MF,
Sheng XF and Ren KQ: Casticin induces ovarian cancer cell apoptosis
by repressing FoxM1 through the activation of FOXO3a. Oncol Lett.
5:1605–1610. 2013.PubMed/NCBI
|
|
13
|
Liu E, Kuang Y, He W, Xing X and Gu J:
Casticin induces human glioma cell death through apoptosis and
mitotic arrest. Cell Physiol Biochem. 31:805–814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen JK, Du HP, Yang M, Wang YG and Jin J:
Casticin induces leukemic cell death through apoptosis and mitotic
catastrophe. Ann Hematol. 88:743–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu L, Liu FX, Cao XC, Xiao Q, Yang X and
Ren KQ: Activation of the apoptosis signal-regulating kinase
1/c-Jun N-terminal kinase pathway is involved in the
casticin-induced apoptosis of colon cancer cells. Exp Ther Med.
8:1494–1500. 2014.PubMed/NCBI
|
|
16
|
Garbe C and Leiter U: Melanoma
epidemiology and trends. Clin Dermatol. 27:3–9. 2009. View Article : Google Scholar
|
|
17
|
Jilaveanu LB, Aziz SA and Kluger HM:
Chemotherapy and biologic therapies for melanoma: Do they work?
Clin Dermatol. 27:614–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lillehammer T, Engesaeter BO, Prasmickaite
L, Maelandsmo GM, Fodstad O and Engebraaten O: Combined treatment
with Ad-hTRAIL and DTIC or SAHA is associated with increased
mitochondrial-mediated apoptosis in human melanoma cell lines. J
Gene Med. 9:440–451. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang YM, Velmurugan BK, Kuo WW, Chen YS,
Ho TJ, Tsai CT, Ye CX, Tsai CH, Tsai FJ and Huang CY: Inhibitory
effect of alpinate Oxyphyllae fructus extracts on Ang II-induced
cardiac pathological remodeling-related pathways in H9c2
cardiomyoblast cells. BioMedicine. 3:148–152. 2013. View Article : Google Scholar
|
|
21
|
Chueh FS, Chen YL, Hsu SC, Yang JS, Hsueh
SC, Ji BC, Lu HF and Chung JG: Triptolide induced DNA damage in
A375.S2 human malignant melanoma cells is mediated via reduction of
DNA repair genes. Oncol Rep. 29:613–618. 2013.
|
|
22
|
Roos WP and Kaina B: DNA damage-induced
cell death by apoptosis. Trends Mol Med. 12:440–450. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hsu YC, Weng HC, Lin S and Chien YW:
Curcuminoids cellular uptake by human primary colon cancer cells as
quantitated by a sensitive HPLC assay and its relation with the
inhibition of proliferation and apoptosis. J Agric Food Chem.
55:8213–8222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ireson C, Orr S, Jones DJ, Verschoyle R,
Lim CK, Luo JL, Howells L, Plummer S, Jukes R, Williams M, et al:
Characterization of metabolites of the chemopreventive agent
curcumin in human and rat hepatocytes and in the rat in vivo, and
evaluation of their ability to inhibit phorbol ester-induced
prostaglandin E2 production. Cancer Res. 61:1058–1064.
2001.PubMed/NCBI
|
|
25
|
Ireson CR, Jones DJ, Orr S, Coughtrie MW,
Boocock DJ, Williams ML, Farmer PB, Steward WP and Gescher AJ:
Metabolism of the cancer chemopreventive agent curcumin in human
and rat intestine. Cancer Epidemiol Biomarkers Prev. 11:105–111.
2002.PubMed/NCBI
|
|
26
|
McCall MR and Frei B: Can antioxidant
vitamins materially reduce oxidative damage in humans? Free Radic
Biol Med. 26:1034–1053. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ohia SE, Opere CA and Leday AM:
Pharmacological consequences of oxidative stress in ocular tissues.
Mutat Res. 579:22–36. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wood RD, Mitchell M, Sgouros J and Lindahl
T: Human DNA repair genes. Science. 291:1284–1289. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Christmann M, Verbeek B, Roos WP and Kaina
B: O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal
tissues and tumors: Enzyme activity, promoter meth-ylation and
immunohistochemistry. Biochim Biophys Acta. 1816:179–190.
2011.PubMed/NCBI
|
|
30
|
Verbeek B, Southgate TD, Gilham DE and
Margison GP: O6-Methylguanine-DNA methyltransferase
inactivation and chemotherapy. Br Med Bull. 85:17–33. 2008.
View Article : Google Scholar
|
|
31
|
Venkitaraman AR: Cancer susceptibility and
the functions of BRCA1 and BRCA2. Cell. 108:171–182. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu X, Gammon MD, Zhang Y, Bestor TH,
Zeisel SH, Wetmur JG, Wallenstein S, Bradshaw PT, Garbowski G,
Teitelbaum SL, et al: BRCA1 promoter methylation is associated with
increased mortality among women with breast cancer. Breast Cancer
Res Treat. 115:397–404. 2009. View Article : Google Scholar :
|
|
33
|
Bartkova J, Horejsí Z, Sehested M, Nesland
JM, Rajpert-De Meyts E, Skakkebaek NE, Stucki M, Jackson S, Lukas J
and Bartek J: DNA damage response mediators MDC1 and 53BP1:
Constitutive activation and aberrant loss in breast and lung
cancer, but not in testicular germ cell tumours. Oncogene.
26:7414–7422. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gorgoulis VG, Vassiliou LV, Karakaidos P,
Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr,
Kastrinakis NG, Levy B, et al: Activation of the DNA damage
checkpoint and genomic instability in human precancerous lesions.
Nature. 434:907–913. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gou Q, Xie Y, Liu L, Xie K, Wu Y, Wang Q,
Wang Z and Li P: Downregulation of MDC1 and 53BP1 by short hairpin
RNA enhances radiosensitivity in laryngeal carcinoma cells. Oncol
Rep. 34:251–257. 2015.PubMed/NCBI
|
|
36
|
Jackson SP: DNA-dependent protein kinase.
Int J Biochem Cell Biol. 29:935–938. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Belenkov AI, Paiement JP, Panasci LC,
Monia BP and Chow TY: An antisense oligonucleotide targeted to
human Ku86 messenger RNA sensitizes M059K malignant glioma cells to
ionizing radiation, bleomycin, and etoposide but not DNA
cross-linking agents. Cancer Res. 62:5888–5896. 2002.PubMed/NCBI
|
|
38
|
Mi J, Dziegielewski J, Bolesta E,
Brautigan DL and Larner JM: Activation of DNA-PK by ionizing
radiation is mediated by protein phosphatase 6. PLoS One.
4:e43952009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shintani S, Mihara M, Li C, Nakahara Y,
Hino S, Nakashiro K and Hamakawa H: Up-regulation of DNA-dependent
protein kinase correlates with radiation resistance in oral
squamous cell carcinoma. Cancer Sci. 94:894–900. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Matuo R, Sousa FG, Escargueil AE,
Grivicich I, Garcia-Santos D, Chies JA, Saffi J, Larsen AK and
Henriques JA: 5-Fluorouracil and its active metabolite FdUMP cause
DNA damage in human SW620 colon adenocarcinoma cell line. J Appl
Toxicol. 29:308–316. 2009. View Article : Google Scholar
|
|
41
|
Jäämaa S, Af Hällström TM, Sankila A,
Rantanen V, Koistinen H, Stenman UH, Zhang Z, Yang Z, De Marzo AM,
Taari K, et al: DNA damage recognition via activated ATM and p53
pathway in nonproliferating human prostate tissue. Cancer Res.
70:8630–8641. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Brum G, Carbone T, Still E, Correia V,
Szulak K, Calianese D, Best C, Cammarata G, Higgins K, Ji F, et al:
N-acetylcysteine potentiates doxorubicin-induced ATM and p53
activation in ovarian cancer cells. Int J Oncol. 42:211–218.
2013.
|
